Why Are COVID Patients Treated With an HIV Pill?<\/i><\/b><\/h2>"},"content":{"rendered":"
Analysis by Dr. Joseph Mercola<\/p>\n
\n
\n
\n
STORY AT-A-GLANCE<\/h3>\n
<\/p>\n
\n
\n
July 25, 2022, Chinese officials granted conditional approval to Azvudine, an HIV drug, to be used as a COVID treatment<\/span><\/li>\n
Use of the HIV drug has reignited interest in early evidence suggesting SARS-CoV-2 is a bioweapon augmented with parts of the HIV virus<\/span><\/li>\n
In late January 2020, Indian researchers published a paper claiming segments of the viral RNA appeared more closely related to HIV than other coronaviruses. The researchers even said SARS-CoV-2 responded to HIV medications<\/span><\/li>\n
The Indian paper was quickly retracted, but not before catching the attention of the late Luc Montagnier, a world-renowned virologist who won the Nobel prize for his discovery of HIV. Montagnier insisted the Indian researchers were correct in their assessment, and had been forced to retract the paper \u201cafter enormous pressure\u201d<\/span><\/li>\n
Several scenarios are now converging to create the suspicion that getting an HIV vaccine to market may be a goal behind COVID. The COVID jab is causing AIDS-like immunodepression, which helps create the perception that we have an urgent need for an HIV vaccine<\/span><\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
July 25, 2022, Chinese officials granted conditional approval to an HIV drug to be used as a COVID treatment. As reported by Reuters:1<\/span><\/sup><\/p>\n
\u201cThe Azvudine tablet, which China approved in July last year to treat certain HIV-1 virus infections, has been given a conditional green light to treat adult patients with \u2018normal type\u2019 COVID, the National Medical Products Administration said in a statement.<\/em><\/p><\/blockquote>\n
\u2018Normal type\u2019 COVID is a term China uses to refer to coronavirus infections where there are signs of pneumonia, but the patients haven’t reached a severe stage … In a late-stage clinical trial, 40.4% of patients taking Azvudine showed improvement in symptoms seven days after first taking the drug, compared with 10.9% in the control group …\u201d<\/em><\/p><\/blockquote>\n
The use of the HIV drug has reignited interest in early evidence suggesting SARS-CoV-2 is a bioweapon augmented with parts of the HIV virus.<\/p>\n
HIV Insertions Highlighted in Early 2020<\/h2>\n
January 31, 2020, ZeroHedge published an article2<\/span><\/sup>\u00a0featuring the findings3<\/span><\/sup>\u00a0of Indian researchers, who claimed certain segments of the viral RNA appeared more closely related to HIV than other coronaviruses. The researchers even said SARS-CoV-2 responded to HIV medications.<\/p>\n
According to this paper, titled \u201cUncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag,\u201d the presence of HIV insertions was unlikely to have occurred naturally \u2014 the implication being that SARS-CoV-2 might be an escaped bioweapon:4<\/span><\/sup><\/p>\n
\u201cWe found 4 insertions in the spike glycoprotein (S) which are unique to the 2019-nCoV and are not present in other coronaviruses. Importantly, amino acid residues in all the 4 inserts have identity or similarity to those in the HIV-1 gp120 or HIV-1 Gag.<\/em><\/p><\/blockquote>\n
\n
<\/div>\n
Interestingly, despite the inserts being discontinuous on the primary amino acid sequence, 3D-modelling of the 2019-nCoV suggests that they converge to constitute the receptor binding site. The finding of 4 unique inserts in the 2019-nCoV, all of which have identity \/similarity to amino acid residues in key structural proteins of HIV-1 is unlikely to be fortuitous in nature.\u201d<\/em><\/p><\/blockquote>\n
Within days, ZeroHedge\u2019s article had caught the attention of Jeremy Farrar \u2014 director of the Wellcome Trust \u2014 who emailed it to Dr. Anthony Fauci.5<\/span><\/sup><\/p>\n
<\/div>\n
The Indian paper was quickly retracted, but not before catching the attention of the late Luc Montagnier, a world-renowned French virologist who won the Nobel prize for his discovery of HIV.<\/p>\n
His belief that SARS-CoV-2 did contain sequences of the HIV virus6<\/span><\/sup>\u00a0was in part why AP News named him as one of the top \u201csuperspreaders of disinformation\u201d about SARS-CoV-2\u2019s origin in 2021.7<\/span><\/sup>\u00a0Montagnier insisted the Indian researchers were correct in their assessment, and had been forced to retract the paper \u201cafter enormous pressure.\u201d8<\/span>,9<\/span><\/sup><\/p>\n
AIDS Awareness Back \u2018In Vogue\u2019<\/h2>\n
Then, in February 2022, AIDS was suddenly all the rage. Media seemingly abandoned COVID overnight, taking aim at AIDS instead, and when all the media start raising an issue at the same time, it\u2019s usually a coordinated campaign directed by a PR company on the behalf of a client.<\/p>\n
There\u2019s a reason for it, and the reason is to sow a desired narrative in the minds of people. They plant ideas so that when something happens, people are already prepped with certain prejudices or assumptions. So, what then might be the reason for\u00a0everyone suddenly talking about AIDS<\/a>?<\/p>\n
![\"azvudine](\"https:\/\/media.mercola.com\/ImageServer\/Public\/2022\/August\/Nonlead\/azvudine-covid.jpg\")
<\/p>\n![\"Dr.](\"https:\/\/media.mercola.com\/ImageServer\/public\/2022\/August\/dr-anthony-fauci-email.jpg\")
<\/div>\n